Luis Sanay | Head-Investor Relations |
John Jacobs | President & Chief Executive Officer |
Jeffrey Dierks | Chief Commercial Officer |
Jeffrey Dayno | Chief Medical Officer |
Sandip Kapadia | Chief Financial Officer |
Francois Brisebois | Oppenheimer |
David Amsellem | Piper Sandler |
Charles Duncan | Cantor Fitzgerald |
Corinne Jenkins | Goldman Sachs |
Chris Howerton | Jefferies |
Graig Suvannavejh | Mizuho Securities |
Good morning. My name is Gretchin, and I will be your conference operator today. At this time, I would like to welcome everyone to the Harmony Biosciences Third Quarter 2022 Financial Results Conference Call. All participant lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session.